Summary of Bill S 748

Bill Overview

• Bill Number: S 748
• Title: Makes technical changes to certain provisions requiring epinephrine auto-injector devices to be made available in places of public assembly
• Status: Substituted by A 692
• Introduced On: January 08, 2025
• Classification: Legislative Bill

Purpose and Intent

Bill S 748 aims to enhance public safety by ensuring that epinephrine auto-injector devices are readily available in places of public assembly. This legislation is particularly important for individuals who may experience severe allergic reactions (anaphylaxis) in crowded or public settings, where immediate access to epinephrine can be life-saving.

Key Provisions

While the specific text of the bill is not provided, the intent of S 748 includes:
- Technical Changes: The bill proposes to make necessary technical adjustments to existing laws regarding the availability and accessibility of epinephrine auto-injectors in public venues.
- Public Assembly Requirements: It emphasizes the requirement for public assembly locations (such as schools, stadiums, and community centers) to have these devices on hand.

Affected Parties

• Public Venues: Places of public assembly will be directly impacted as they will need to comply with the updated requirements for epinephrine auto-injectors.
• Individuals with Allergies: The legislation primarily benefits individuals who are at risk of anaphylaxis, providing them with greater safety and peace of mind in public spaces.

Legislative Timeline

• January 08, 2025: Bill S 748 was introduced and referred to the Rules Committee.
• January 13, 2025: The bill was ordered to third reading, indicating it was moving forward in the legislative process.
• February 03, 2025: The bill was substituted by A 692, which is a companion bill that likely incorporates similar provisions or further refines the original intent of S 748.

Related Legislation

• A 692: This companion bill serves as the substitute for S 748 and may contain similar or expanded provisions regarding the availability of epinephrine auto-injectors in public settings.

Conclusion

Bill S 748 represents a legislative effort to improve public health safety by ensuring that epinephrine auto-injectors are accessible in public assembly areas. The substitution of this bill by A 692 indicates a continued legislative focus on this important health issue. The changes proposed aim to protect individuals at risk of severe allergic reactions, thereby enhancing overall public safety in communal environments.